David E Housman

Plain English
This study explored the genes that influence Huntington's disease (HD), particularly how they affect the structure and development of brain cells. The researchers tested 21 specific genes and found both familiar and surprising connections between these genes and the physical characteristics of neurons. They discovered new insights into how certain genetic factors modify HD, which is crucial for improving understanding and treatment. Who this helps: This helps patients with Huntington's disease and researchers studying neurological disorders.

Plain English
This study looked at a rare genetic change that appears to help people resist neurodegenerative diseases, particularly Huntington's disease. Researchers found that this genetic variant can delay the onset of the disease by as much as 23 years, and when they introduced this change into mice, it significantly slowed the progression of symptoms. This discovery is important because it identifies a common target for treatments that could benefit people suffering from various neurological disorders. Who this helps: This helps patients with neurodegenerative diseases and their doctors.

Plain English
This study focused on the Huntingtin (HTT) protein to understand its role in a process called autophagy, which helps clear damaged cellular components in the body. Researchers found that HTT directly interacts with a molecule called ubiquitin and that mutated HTT (with an expanded polyglutamine sequence) affects how well this clearance process works. Specifically, in cells lacking HTT, there were fewer mitochondrial proteins in the lysosomes (which help break down waste) and an increase in other proteins, suggesting a disruption in the normal cleaning process. Who this helps: This research benefits patients with Huntington's disease and their doctors by providing insights into how HTT mutations contribute to the disease.

Plain English
This study investigated how certain brain cells called astrocytes behave in Huntington's disease (HD) and how this relates to the disease's effects on specific brain regions. Researchers found that a specific type of astrocyte is linked to protecting certain neurons from dying, even when they face threats from the disease. Their experiments showed that enhancing these astrocytes helped HD-related brain cells survive better, indicating that targeting astrocytes could be an important strategy in treating HD. Who this helps: This helps patients with Huntington's disease and their doctors.

Plain English
Researchers looked at how breast cancer cells adapt their metabolism when they spread to the brain. They found that these cells make more fatty acids when growing in the brain compared to other areas, which helps them survive where nutrients are limited. Blocking the process that produces these fatty acids slowed down the growth of HER2+ breast tumors in the brain, showing a potential new way to treat brain metastases. Who this helps: This benefits patients with HER2+ breast cancer that has spread to the brain.

Plain English
This study looked at how drug use, specifically amphetamines, affects brain changes in mice and leads to repetitive behaviors. Researchers found that certain gene changes occurred in the brains of mice showing these behaviors, particularly in a group that reacted strongly to the drugs, with 20 unique genes being affected. This matters because it highlights a potential biological link between drug use and disorders like schizophrenia and autism, suggesting that these changes in gene activity could play a role in making some people more vulnerable to these conditions. Who this helps: This helps researchers and doctors understand the relationship between drug use and mental health disorders.

Plain English
This study focused on a protein called CalDAG-GEFI (CDGI) that plays an important role in how certain brain cells work, particularly in the striatum, which is involved in movement and behavior. The researchers found that when CDGI was removed in mice, it led to problems with how these brain cells communicated and made it harder for the animals to learn sequences properly. Additionally, the mice showed increased repetitive behaviors and less control over drug-seeking actions, pointing to CDGI's important role in movement disorders like Huntington's disease and Parkinson's disease. Who this helps: This research benefits patients with movement disorders and their doctors by highlighting a potential target for new treatments.

Plain English
This study focused on two drugs, tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF), to see how well they can stop the Epstein-Barr virus (EBV) from becoming active and causing diseases like cancer. The researchers found that TAF is much more effective than traditional treatments, being up to 35 times stronger in inhibiting the virus, with specific doses that were highly effective (0.30 μM for TDF and 84 nM for TAF). This is important because these drugs could potentially help prevent the health problems caused by chronic EBV infections, especially since current treatments have many limitations. Who this helps: This research benefits patients at risk for EBV-related cancers and diseases, as well as doctors looking for better treatment options.

Plain English
This study looked at how blocking a specific protein called IKKβ affects Huntington's disease in mice. Researchers found that when IKKβ was removed, the mice showed worse symptoms of Huntington's disease, which correlated with lower levels of a specific form of the Huntington protein (S13-phospho HTT) known to protect brain cells. These findings suggest that IKKβ plays an important role in slowing the progression of Huntington's disease by helping maintain healthy brain function. Who this helps: This helps patients with Huntington's disease by offering insights into potential new treatment strategies.

Plain English
This study looked at early genetic changes in mice that mimic Huntington's disease, a serious disorder that affects the brain. Researchers found that before symptoms appeared, there were noticeable changes in gene activity, particularly involving a protein called Elk-1, which changed how certain genes were expressed. When they increased levels of Elk-1 in cell cultures and mouse models, it helped correct some of these early genetic changes, suggesting that targeting Elk-1 could be a way to treat or manage Huntington's disease. Who this helps: This benefits patients with Huntington's disease and their families by providing a possible new treatment target.

Plain English
This study looked at a patient with multiple sclerosis (MS) who was treated with a combination of two antiviral medications called zidovudine and lamivudine. After starting this treatment, the patient experienced a complete reduction in fatigue and other symptoms, along with improvements seen on MRI scans, and these benefits lasted for over three years. This is important because it suggests that these antiviral drugs might help manage MS symptoms by targeting a virus known as EBV, which may play a role in the disease. Who this helps: This benefits patients with multiple sclerosis, especially those looking for new treatment options.

Plain English
Researchers studied the effects of specific mutations in the TDP-43 protein in mice to understand how they relate to amyotrophic lateral sclerosis (ALS). They found that these mutations led to a gain of splicing function, resulting in changes in gene expression and causing motor neuron damage, which mimicked some ALS symptoms. This discovery helps clarify how TDP-43 mutations contribute to ALS pathology and may inform new approaches to treatment. Who this helps: This helps patients with ALS and the doctors treating them.

Plain English
This study examined how a genetic mutation affects muscle function over time in a disorder called spinal and bulbar muscular atrophy. Researchers found that the mutation significantly reduced the genes needed for the proteasome, which is responsible for getting rid of damaged proteins, leading to 30% fewer proteasome subunits and 20% fewer E2 ubiquitin conjugases in muscle tissues. This impairment contributes to muscle dysfunction and the worsening of symptoms as patients age. Who this helps: This research benefits patients with spinal and bulbar muscular atrophy by providing insights into the mechanisms of their disease and potential targets for treatment.

Plain English
This study looks at how advances in DNA sequencing technology can improve healthcare and highlights the important role of nurses in helping patients understand their genetic information. It found that nurses are essential in using this technology to improve patient education and care, particularly in newborn screening, showing that nurses can help interpret complex genetic data. This matters because better understanding and communication of genetic information can lead to improved health outcomes for patients. Who this helps: Patients and their families, especially newborns and individuals undergoing genetic testing.

Plain English
This study examined brain cells involved in the blood-brain barrier in people with Huntington's disease (HD) to see if they were functioning properly. Researchers found that cells from HD patients had significant problems, including a 50% reduction in the ability to form new blood vessels and compromised barrier properties. Understanding these issues is crucial because they may help develop better treatments for HD and improve drug delivery to the brain. Who this helps: This benefits patients with Huntington's disease and researchers working on treatments.

Plain English
This study examined how certain genetic factors affect the length of a specific DNA repeat associated with Friedreich's ataxia, a hereditary disease. Researchers discovered that mutations in a gene called Ysh1 lead to a significant increase in the size of these repeats when the DNA is being copied into RNA, indicating that this process may worsen the disease. Understanding these factors is crucial because it could help in developing new treatments for repeat expansion diseases. Who this helps: This benefits patients with Friedreich's ataxia and similar genetic conditions.

Plain English
This study developed a software tool called ExpansionHunter to accurately detect large expansions of short DNA sequences that can lead to diseases like amyotrophic lateral sclerosis (ALS) and fragile X syndrome. When tested on DNA data from 3001 ALS patients, ExpansionHunter correctly identified 208 out of 212 patients with disease-related expansions and confirmed that 99.9% of samples without these expansions were classified correctly. This tool is important because it can help researchers quickly find harmful genetic changes, leading to better diagnosis and treatment options. Who this helps: Patients with genetic disorders and their doctors.

Plain English
This study examined how mice respond to heat stress and how this response is affected by Huntington's disease. Researchers found that while certain stress-related genes need a specific protein called HSF1 to be activated, other genes connected to the body’s internal clock can be regulated without it. They also discovered that in mice with Huntington's disease, the heat stress response is weakened. Who this helps: This research helps scientists and doctors better understand how Huntington's disease affects stress responses in the body.

Plain English
This study examined how mutations in a specific enzyme called GPT2 affect brain development and function. Researchers found that people with these mutations often experience intellectual and developmental disabilities, smaller head sizes, and progressive motor issues, with about 80% of affected individuals showing difficulty with movement over time. These findings are important because they not only highlight the role of GPT2 in brain health but also connect it to broader metabolic problems that could contribute to neurodegenerative diseases. Who this helps: This helps patients with neurological disorders and their families.

Plain English
This study investigated a specific part of the brain's dopamine system, focusing on a unique structure called "striosome-dendron bouquets." Researchers found that these structures connect to dopamine neurons, which play a key role in movement and motivation, and could be involved in disorders like Parkinson's disease. The discovery of these bouquets helps us understand how different brain regions influence dopamine activity, which is important for both healthy functioning and in the context of diseases. Who this helps: This helps patients with movement disorders and their doctors by providing insights into potential new treatment avenues.

Plain English
This study looked at the normal role of the Huntingtin (HTT) protein, which is linked to Huntington's disease. Researchers found that HTT is important for a process called selective autophagy, which helps cells break down and recycle components. In experiments, they found that, without HTT, fruit flies and mice showed signs of disrupted cell function, like an accumulation of specific proteins over time. This matters because it sheds light on how HTT's normal function could be related to the development of Huntington's disease and might help in developing new treatments. Who this helps: This helps patients with Huntington’s disease and their doctors.

Plain English
This study looks at Huntington's disease, focusing on the problems caused by a faulty gene and the challenges in finding effective treatments. Despite two decades of research, there are still no treatments that change the disease's course or improve patients' lifespans. However, there is hope due to advances in understanding the disease and developing new drugs and therapies, with scientists and doctors eager to keep testing new possibilities. Who this helps: This helps patients with Huntington's disease and their families.

Plain English
This study looked at ways to quickly find potential treatments for Huntington's Disease (HD) by testing different genetic tools in mice that show HD symptoms. Researchers used a method that can measure disease progression and found which genetic tools were best at stopping the symptoms in these mice. They used a clever approach with pooled samples, leading them to identify effective treatments more efficiently. Who this helps: This helps researchers and doctors looking for new treatments for patients with Huntington's Disease.

Plain English
This study focused on Huntington disease (HD), a genetic condition that leads to severe neurological decline. Researchers found that a specific genetic change causes an abnormal form of the huntingtin protein (exon 1 HTT) to be produced, which is linked to the disease's harmful effects. Understanding this process is crucial because it can inform new treatments aimed at reducing harmful protein levels and potentially improve outcomes for affected individuals. Who this helps: This helps patients with Huntington disease and their families.

Plain English
This study looked at how a specific change in the huntingtin protein affects gene activity in Huntington's disease, focusing on changes in DNA methylation. Researchers found that many genes expressed differently in cells with the mutated huntingtin also had notable changes in their DNA methylation, especially in areas previously linked to brain activity. Understanding these changes is important because they could explain how Huntington's disease affects brain health and thinking abilities. Who this helps: This helps patients with Huntington's disease and their healthcare providers.

Plain English
This study looked at a new potential treatment for Huntington's disease (HD) by using a protein called ApiCCT1, which can help prevent the harmful buildup of a misfolded version of the Huntingtin protein. Researchers found that ApiCCT1 can enter cells and reduce the formation of toxic aggregates by decreasing visible clumps and delaying when they form, leading to less cellular damage. This finding is important because it reveals a new way to approach treatment for HD, which currently has limited options. Who this helps: This helps patients with Huntington's disease by potentially offering a new therapeutic option.

Plain English
This study looked at a large group of cancer cell lines to find effective combinations of drug targets that could improve treatment outcomes. Researchers tested 37 new targeted drugs on 669 cancer cell lines, discovering biomarker patterns that could predict how well these cancers respond to treatments. They found specific genomic changes that often occur together and can help guide effective drug combinations, which could prevent cancer from becoming resistant to treatments in the future. Who this helps: This helps cancer patients by improving treatment strategies and outcomes.

Plain English
This study looked at mutations in the FUS gene, which are linked to familial amyotrophic lateral sclerosis (ALS), a severe nerve disease that weakens muscles. Researchers found that when normal and mutant forms of the FUS protein were tested in cells, the mutations did not cause a loss of function in the same way expected. Instead, specific mutations (R521G and R522G) affected gene behavior differently, suggesting these mutations have a distinct role in ALS development rather than just disabling the gene's function. Who this helps: This research benefits scientists and doctors studying ALS, as it offers new insights into how FUS mutations contribute to the disease.

Plain English
This study looked at a specific change in the brain cells of people and mice with Huntington disease (HD) that affects how genes are turned on or off. Researchers found that reducing the activity of a protein called SMCX/Jarid1c improved the expression of important genes that help brain cells function, showing potential benefits in both mouse models and fruit flies. This matters because it suggests that targeting this particular protein could lead to new treatments for HD that help protect brain function. Who this helps: This helps patients with Huntington disease.

Plain English
This study focused on understanding how the marine diatom Pseudo-nitzschia multiseries produces domoic acid, a harmful neurotoxin. Researchers examined the gene activity in the diatom under conditions that promoted high and low levels of toxin production, identifying specific genes tied to these changes. They found that certain genes were more stable and reliable for measuring this activity, which helps to improve our knowledge of how this dangerous substance is produced and can affect both human health and the environment. Who this helps: This benefits researchers studying marine toxins and health officials monitoring food safety.

Plain English
This study looked at how glioblastoma multiforme (GBM), a dangerous type of brain tumor, resists treatment that targets a protein called EGFR. Researchers created a special mouse model to study this resistance and discovered that when the MET protein was activated, it helped the tumors avoid being harmed by EGFR inhibitors. They found that blocking MET could reverse this resistance, indicating that targeting both EGFR and MET might be more effective for treating GBM patients. Who this helps: This benefits patients with glioblastoma multiforme and their doctors.

Plain English
Researchers studied how a specific dopamine receptor (D2) changes in mice that model Huntington's disease (HD), which is a serious brain disorder. They found that the levels of this receptor decreased in these mice and that a new method they developed can accurately measure this change over time. This is important because it provides a reliable way to assess potential treatments for HD in future studies. Who this helps: This helps patients with Huntington's disease by providing a new tool for developing and testing therapies.

Plain English
This study looked at how ribosomal proteins (RPGs) affect the way microRNAs (miRNAs) control gene expression in humans. Researchers found that when the levels of RPGs were reduced, it led to less repression of target mRNAs by miRNAs, resulting in a significant increase in the translation (or protein production) of those mRNAs—about a 50% increase compared to mRNAs not targeted by miRNAs. This matters because it helps to better understand the regulation of gene expression, which can have implications for various diseases where this process goes awry. Who this helps: This helps researchers and doctors looking for new ways to treat diseases linked to gene regulation.

Plain English
This study looked at how muscleblind proteins affect RNA processing and placement in cells from the brain, heart, and muscles. Researchers found that muscleblind proteins play a crucial role in splicing hundreds of RNA strands; specifically, they influence whether certain parts of RNA are included or excluded from the final message, with important patterns seen between two types of muscleblind proteins. This is significant because understanding how these proteins work can help explain the development of diseases like myotonic dystrophy, which can lead to muscle and eye disorders. Who this helps: This benefits patients with myotonic dystrophy and their doctors.

Plain English
This study looked at how certain genetic changes in mice lead to the development of aggressive brain tumors called glioblastomas. Researchers found that activating the epidermal growth factor receptor (EGFR) continuously and losing a tumor-suppressing gene resulted in tumors that closely resemble those found in humans. They discovered that treating these tumors with a specific drug led to significant cell death, but certain mutations often found in human tumors did not affect the treatment's effectiveness. Who this helps: This research benefits doctors and researchers developing targeted therapies for glioblastoma patients.

Plain English
This study looked at the genetic factors linked to a heart condition called Bicuspid Aortic Valve (BAV), which affects about 1% of the population. Researchers analyzed genetic data from 68 individuals with BAV and 830 without it, identifying specific genetic patterns associated with the condition. They discovered strong genetic links with the AXIN1-PDIA2 area and the Endoglin gene, which could improve our understanding of the causes of BAV and help develop better treatments. Who this helps: This helps patients with BAV and their doctors by providing insights into the genetic aspects of the condition.

Plain English
Researchers studied the role of a protein called CalDAG-GEFI in Huntington's disease (HD), which causes severe damage to brain areas involved in movement and coordination. They found that in mice with HD, levels of CalDAG-GEFI were significantly reduced, especially in neurons with the most harmful forms of the Huntington protein. Importantly, lowering CalDAG-GEFI in lab models helped protect neurons from damage caused by the disease. Who this helps: This research benefits patients with Huntington's disease, as understanding CalDAG-GEFI could lead to new protective treatments.

Plain English
This study introduces a new tool called Hapi, which quickly analyzes genetic information from family groups to determine the most likely combinations of genes (haplotypes). When tested on data from 103 families, Hapi was found to be 3.8 to 320 times faster than existing methods while producing highly accurate results. This is important because it allows researchers and doctors to better understand genetic relationships in a family, which can improve disease diagnosis and treatment plans. Who this helps: Patients and doctors who need faster and more accurate genetic testing.

Plain English
This research studied how the size of a specific genetic marker (CAG repeats) in the Huntington's disease (HD) gene changes when passed down through families in Venezuela. The study found that CAG repeat sizes between 27 and 35 remain stable when inherited, with no changes leading to disease symptoms in individuals aged 11 to 82. However, 14% of larger CAG repeats (36-39) can increase to sizes that cause symptoms. These findings are important because they can guide genetic counseling for families at risk of Huntington's disease. Who this helps: Families with a history of Huntington's disease.

Plain English
This study looked at how certain gene variations related to estrogen may affect stiffness in blood vessels, which is a risk factor for heart disease. Researchers analyzed data from 1,261 participants, finding that people with specific variations in the ESR1 gene had, on average, 18% higher blood pressure measurements and a 16% increase in a measure called the augmentation index, which reflects how blood pressure waves are amplified in the arteries. This is important because it suggests that these gene variations could contribute to heart disease risk and that understanding these differences could lead to better health strategies. Who this helps: This helps patients, especially those at risk for cardiovascular diseases.

Plain English
This study looked at how mutations in the epidermal growth factor receptor (EGFR) influence the development of glioblastoma multiforme (GBM), a deadly brain tumor. Researchers found that when both normal and mutated EGFR were active, along with the loss of certain tumor suppressor genes, it led to the rapid growth of tumors in mice that closely resembled human GBM. This research reveals important differences in how tumors with normal versus mutated EGFR operate, which could guide future treatments targeting these pathways. Who this helps: This helps patients with glioblastoma, researchers, and doctors looking for better treatment options.

Plain English
This research focused on creating a new method to measure specific proteins in cells, particularly the mutant form of a protein linked to Huntington's disease. The scientists designed a simple test that can detect low amounts of this harmful protein quickly and efficiently using a special tagging technique. They found that this method not only identifies changes in the protein levels but also helps in spotting potential treatments, with the ability to test many samples at once. Who this helps: This helps researchers and drug developers working on therapies for Huntington's disease.

Plain English
In this study, researchers looked at how certain genetic variations related to estrogen affect hormone levels and heart health in men and women. They found that specific gene variations, especially in a gene called CYP19A1, led to higher estrogen and lower testosterone levels in men, which could impact heart disease risk. For example, men with a particular genetic variant had 5% higher estradiol and 17% lower testosterone per genetic copy. This information is important because understanding these genetic links can help identify people who may be at risk for heart issues and guide more effective prevention strategies. Who this helps: This research benefits patients at risk for cardiovascular disease, particularly those with genetic predispositions.

Plain English
This study looked at genetic factors that influence when people develop Huntington's disease, focusing on families in Venezuela where the disease was first identified. Researchers found two new genetic locations on chromosome 2 that may affect the age of onset of the disease, with one area showing strong evidence (LOD=4.29) and another showing moderate evidence (LOD=3.39). These findings are important because they could lead to new treatments to delay or prevent the disease's effects. Who this helps: This helps patients and their families affected by Huntington's disease.

Plain English
This study looked at how a specific protein pathway in cancer cells, called mTORC1, influences their survival and response to treatment. Researchers found that when a certain gene (TSC2) was missing in mice with lymphoma, the cancer grew faster due to a flawed ability to die off when needed. By blocking mTORC1 with a drug called rapamycin, these cancers underwent rapid cell death, which was linked to changes in another protein called Mcl-1. This research is important because understanding how mTORC1 and Mcl-1 work together can lead to better cancer treatments that make tumors more vulnerable to chemotherapy. Who this helps: This helps patients with cancer, particularly those who struggle with treatment resistance.

Plain English
This study looked at how having an abnormal number of chromosomes, a condition called aneuploidy, affects mouse cells. Researchers created cells with an extra copy of certain chromosomes and found that these cells grew more slowly and had changes in their metabolism. The presence of extra chromosomes also made it harder for these cells to grow indefinitely, which is a characteristic of cancer cells. This research is important because it highlights how aneuploidy negatively impacts both the health of organisms and the behavior of their cells. Who this helps: This helps patients with cancer and genetic disorders, as well as healthcare providers in understanding chromosome-related conditions.

Plain English
This study looked at a unique small molecule that helps remove harmful fragments of a protein associated with Huntington's disease. The researchers found compounds that effectively cleared mutant huntingtin fragments, which are linked to the disease's progression, while leaving normal fragments unharmed. This is important because it could lead to new treatments that specifically target the toxic aspects of Huntington's without affecting healthy proteins. Who this helps: This helps patients with Huntington's disease.

Plain English
Researchers studied a new drug called C2-8 to see if it can help treat Huntington's disease, a condition that causes the brain to gradually decline. They found that C2-8 not only successfully reduced harmful protein clumps in mice but also improved motor skills and decreased brain cell damage. This is important because it provides a promising new avenue for developing therapies for Huntington's disease. Who this helps: This helps patients with Huntington's disease and their families.

Plain English
Researchers created mice missing a protein called CalDAG-GEFI and found that this single missing protein causes multiple problems across different types of blood cells—specifically preventing certain immune cells and platelets from sticking to blood vessel walls and doing their jobs. This discovery explains how a rare human disease called LAD-III can cause widespread blood cell dysfunction from just one genetic defect, rather than requiring separate mutations in multiple genes. The findings provide doctors with a model to understand and potentially treat this serious human condition where the immune system and blood clotting don't work properly.